Skip to Content
Merck

441236

Ethyl 2-(ethoxymethylene)-4,4,4-trifluoro-3-oxobutyrate,mixture of cis and trans

96%

Sign In to View Organizational & Contract Pricing.

Select a Size

10 G

PLN 532.50

PLN 532.50

List PricePLN 710.00Save 25%

Please contact Customer Service for Availability

Request a Bulk Order

About This Item

Linear Formula:
CF3COC(=CHOC2H5)CO2C2H5
CAS Number:
Molecular Weight:
240.18
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
MDL number:

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Ethyl 2-(ethoxymethylene)-4,4,4-trifluoro-3-oxobutyrate,mixture of cis and trans, 96%

InChI

1S/C9H11F3O4/c1-3-15-5-6(8(14)16-4-2)7(13)9(10,11)12/h5H,3-4H2,1-2H3/b6-5+

SMILES string

CCO\C=C(\C(=O)OCC)C(=O)C(F)(F)F

InChI key

XNGGOXOLHQANRB-AATRIKPKSA-N

assay

96%

form

liquid

refractive index

n20/D 1.429 (lit.)

bp

80-82 °C/1 mmHg (lit.)

density

1.235 g/mL at 25 °C (lit.)

functional group

ester
ether
fluoro
ketone

storage temp.

2-8°C

Quality Level

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
401455218456374881
assay

96%

assay

97%

assay

97%

assay

98%

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

bp

80-82 °C/1 mmHg (lit.)

bp

96-98 °C (lit.)

bp

62 °C/11 mmHg (lit.)

bp

86-90 °C/14 mmHg (lit.)

density

1.235 g/mL at 25 °C (lit.)

density

1.162 g/mL at 25 °C (lit.)

density

0.989 g/mL at 25 °C (lit.)

density

-

storage temp.

2-8°C

storage temp.

-

storage temp.

2-8°C

storage temp.

-

form

liquid

form

liquid

form

-

form

-

Application

Ethyl 2-(ethoxymethylene)-4,4,4-trifluoro-3-oxobutyrate may be employed as a starting reagent for the synthesis of 1-methyl-3-trifluoromethyl-1H-pyrazole-4- carboxylic acid.[1]

General description

Ethyl 2-(ethoxymethylene)-4,4,4-trifluoro-3-oxobutyrate has been reported to participate in the microwave-assisted synthesis of ethyl 1-[4-(2,3,3-trichloroacrylamido)phenyl]-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate.[2]

Storage Class

10 - Combustible liquids

wgk

WGK 3

flash_point_f

219.2 °F - closed cup

flash_point_c

104.00 °C - closed cup

ppe

Eyeshields, Gloves


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

European Journal of Medicinal Chemistry, 28, 853-853 (1993)
R D Franz
AAPS pharmSci, 3(2), E10-E10 (2001-12-14)
The changes in the physiochemical properties accompanying the substitution of a phosphonic acid group for a carboxylic acid group on various heterocyclic platforms was determined. A series of low molecular weight heterocyclic carboxylic and phosphonic acids was prepared, and the
L Mosti et al.
Farmaco (Societa chimica italiana : 1989), 47(4), 427-437 (1992-04-01)
The synthesis of ethyl or methyl esters of 5-cyano-1,6-dihydro-6-oxo-3- pyridinecarboxylic acids carrying as 2-substituent a polar group such as CO2C2H5, (CH2)2CO2CH3, (CH2)3CO2C2H5, CH2OCH3, or CF3 group is described. Also 2-[5-cyano-1,6-dihydro-2-(1,1-dimethylethyl)-6-oxo-3-pyridyl]-2- oxoacetic acid and 2,5,6,8-tetrahydro-2,5-dioxo-1H-thiopyrano[3,4-b]pyridine-3-carbon itrile were prepared. Nearly all the
L Sansebastiano et al.
Farmaco (Societa chimica italiana : 1989), 48(3), 335-355 (1993-03-01)
The synthesis of ethyl or methyl 4-substituted or unsubstituted 2-methylthio-5-pyrimidinecarboxylates 3 a-i and 8 o mainly by reaction of ethyl or methyl 2-dimethylaminomethylene-3-oxoalkanoates with 2-methylisothiourea is described. Also some ethyl 2-substituted (NH2, CH3, C6H5) 4-trifluoromethyl-5-pyrimidinecarboxylates were prepared. Some of the
P J Sanfilippo et al.
Journal of medicinal chemistry, 38(1), 34-41 (1995-01-06)
The synthesis and biological activity of novel thiazole-based heterocycles as inhibitors of thrombin-induced human platelet aggregation are described. Further evaluation of selected compounds show they inhibit platelet aggregation as stimulated by a variety of agonists. The more active compounds also

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service